International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 2 , Pages 516-522 , 1 June 2010

Radiotherapy Can Decrease Locoregional Recurrence and Increase Survival in Mastectomy Patients With T1 to T2 Breast Cancer and One to Three Positive Nodes With Negative Estrogen Receptor and Positive Lymphovascular Invasion Status

  • Po Sheng Yang, M.D.

      Affiliations

    • Department of Surgery, Sun Yat-Sen Cancer Center, Taipei, Taiwan
    • Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
    • Corresponding Author InformationReprint requests to: Po Sheng Yang, M.D., Department of Surgery, Sun Yat-Sen Cancer Center, 125 Lih-Der Road, Beitou District, Taipei 112, Taiwan. Tel: (+886) 2-28970011; Fax: (+886) 2-28972233
    • ,
  • Chi Ming Chen, M.D.

      Affiliations

    • Department of Surgery, Sun Yat-Sen Cancer Center, Taipei, Taiwan
    • ,
  • Mei Ching Liu, M.D.

      Affiliations

    • Department of Medical Oncology, Sun Yat-Sen Cancer Center, Taipei, Taiwan
    • ,
  • Jer Min Jian, M.D.

      Affiliations

    • Department of Radiation Oncology, Sun Yat-Sen Cancer Center, Taipei, Taiwan
    • ,
  • Cheng Fang Horng, M.S.

      Affiliations

    • Department of Research, Sun Yat-Sen Cancer Center, Taipei, Taiwan
    • ,
  • Ming Jiung Liu, M.D.

      Affiliations

    • Department of Radiation Oncology, Sun Yat-Sen Cancer Center, Taipei, Taiwan
    • ,
  • Ben Long Yu, M.D.

      Affiliations

    • Department of Surgery, Sun Yat-Sen Cancer Center, Taipei, Taiwan
    • ,
  • Ming Yuan Lee, M.D.

      Affiliations

    • Department of Pathology, Sun Yat-Sen Cancer Center, Taipei, Taiwan
    • ,
  • Chin Wen Chi, Ph.D.

      Affiliations

    • Institute of Pharmacology, School of Medicine, National Yang-Ming University, Taipei, Taiwan
    • Department of Medical Research and Education, Taipei Veterans General Hospital, Taipei, Taiwan

Received 15 April 2009 ,Revised 19 May 2009 ,Accepted 19 May 2009.

References 

  1. Lee MC, Jagsi R. Postmastectomy radiation therapy: Indications and controversies. Surg Clin North Am. 2007;87:511–526
  2. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med. 1997;337:949–955
  3. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  4. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  5. Harris JR, Halpin-Murphy P, McNeese M, et al. Consensus statement on postmastectomy radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:989–990
  6. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–1569
  7. Poortmans P. Evidence based radiation oncology: Breast cancer. Radiother Oncol. 2007;84:84–101
  8. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82:247–253
  9. Yildirim E, Berberoglu U. Local recurrence in breast carcinoma patients with T(1-2) and 1-3 positive nodes: Indications for radiotherapy. Eur J Surg Oncol. 2007;33:28–32
  10. Olivotto IA, Truong PT, Chua B. Postmastectomy radiation therapy: Who needs it?. J Clin Oncol. 2004;22:4237–4239
  11. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;366:2087–2106
  12. Truong PT, Berthelet E, Lee J, et al. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer. 2005;103:2006–2014
  13. Katz A, Buchholz TA, Thames H, et al. Recursive partitioning analysis of locoregional recurrence patterns following mastectomy: Implications for adjuvant irradiation. Int J Radiat Oncol Biol Phys. 2001;50:397–403
  14. Yu JM, Wang YS. Breast cancer radiotherapy: Controversies and perspectives. Chin Med J (Engl). 2008;121:1957–1959
  15. Woodward WA, Strom EA, Tucker SL, et al. Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2003;57:336–344
  16. Poortmans P. A bright future for radiotherapy in breast cancer. Radiother Oncol. 2007;82:243–246
  17. Cheng JC, Chen CM, Liu MC, et al. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:980–988
  18. Kuske RR. Adjuvant irradiation after mastectomy in women with one to three positive axillary nodes: Then no; now yes. Semin Radiat Oncol. 1999;9:254–258
  19. Fowble B, Gray R, Gilchrist K, et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving adjuvant chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol. 1988;6:1107–1117
  20. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial. J Natl Cancer Inst. 2005;97:116–126
  21. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: Results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol. 2004;22:4247–4254
  22. Clayton F. Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor. Cancer. 1991;68:1309–1317
  23. Neville AM, Bettelheim R, Gelber RD, et al. Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group. J Clin Oncol. 1992;10:696–705
  24. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med. 2000;124:966–978
  25. Lee AK, DeLellis RA, Silverman ML, et al. Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast. J Clin Oncol. 1990;8:1457–1465
  26. Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50:735–742
  27. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: Experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689–1700
  28. Nielsen HM, Overgaard M, Grau C, et al. Study of failure pattern among high-risk breast cancer patients with or without postmastectomy radiotherapy in addition to adjuvant systemic therapy: Long-term results from the Danish Breast Cancer Cooperative Group DBCG 82 b and c randomized studies. J Clin Oncol. 2006;24:2268–2275
  29. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol. 2000;18:2817–2827
  30. Truong PT, Jones SO, Kader HA, et al. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy. Int J Radiat Oncol Biol Phys. 2009;73:357–364
  31. Truong PT, Olivotto IA, Kader HA, et al. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:1337–1347
  32. Whelan TJ, Julian J, Wright J, et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 2000;18:1220–1229
  33. Patt DA, Goodwin JS, Kuo YF, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005;23:7475–7482

 Conflict of interest: none.

PII: S0360-3016(09)00766-4

doi: 10.1016/j.ijrobp.2009.05.016

International Journal of Radiation Oncology * Biology * Physics
Volume 77, Issue 2 , Pages 516-522 , 1 June 2010

Article Tools

* Image Usage & Resolution